The DOI matches its Crossref record; 201 of the 201 references it cites were found in a registry or an index.
Adverse drug reactions induced by valproic acid
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Medication Use and the Risk of Stevens–Johnson Syndrome or Toxic Epidermal Necrolysis
Roujeau, J.-C., Kelly, J. P., Naldi, L., Rzany, B., Stern, R. S., Anderson, T., Auquier, A., Bastuji-Garin, S., Correia, O., Locati, F., et al. (1995) · New England Journal of Medicine · doi:10.1056/nejm199512143332404 · Cited by 1,465
Mockenhaupt, M., Viboud, C., Dunant, A., Naldi, L., Halevy, S., Bavinck, J. N. B., Sidoroff, A., Schneck, J., Roujeau, J.-C., & Flahault, A. (2008) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5701033 · Cited by 1,017
The DRESS Syndrome: A Literature Review
Cacoub, P., Musette, P., Descamps, V., Meyer, O., Speirs, C., Finzi, L., & Roujeau, J. C. (2011) · The American Journal of Medicine · doi:10.1016/j.amjmed.2011.01.017 · Cited by 1,012
Morrow, J. (2006) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2005.074203 · Cited by 880
ENCEPHALOPATHY AND FATTY DEGENERATION OF THE VISCERA A DISEASE ENTITY IN CHILDHOOD
Reye, R. D. K., Morgan, G., & Baral, J. (1963) · The Lancet · doi:10.1016/s0140-6736(63)90554-3 · Cited by 819
Cognitive Function at 3 Years of Age after Fetal Exposure to Antiepileptic Drugs
Meador, K. J., Baker, G. A., Browning, N., Clayton-Smith, J., Combs-Cantrell, D. T., Cohen, M., Kalayjian, L. A., Kanner, A., Liporace, J. D., Pennell, P. B., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0803531 · Cited by 812
Tomson, T., Battino, D., Bonizzoni, E., Craig, J., Lindhout, D., Sabers, A., Perucca, E., & Vajda, F. (2011) · The Lancet Neurology · doi:10.1016/s1474-4422(11)70107-7 · Cited by 751
Hepatotoxicity. The adverse effects of drugs and other chemicals on the liver
(1980) · Food and Cosmetics Toxicology · doi:10.1016/0015-6264(80)90206-0 · Cited by 691
Anticonvulsant hypersensitivity syndrome. In vitro assessment of risk.
Shear, N. H., & Spielberg, S. P. (1988) · Journal of Clinical Investigation · doi:10.1172/jci113798 · Cited by 687
Hepatotoxicity: The adverse effects of drugs and other chemicals on the liver
Maddrey, W. C. (2000) · Gastroenterology · doi:10.1016/s0016-5085(00)70192-2 · Cited by 646
Valproic Acid Monotherapy in Pregnancy and Major Congenital Malformations
Jentink, J., Loane, M. A., Dolk, H., Barisic, I., Garne, E., Morris, J. K., & de Jong-van den Berg, L. T. W. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0907328 · Cited by 587
POLG mutations associated with Alpers' syndrome and mitochondrial DNA depletion
Naviaux, R. K., & Nguyen, K. V. (2004) · Annals of Neurology · doi:10.1002/ana.20079 · Cited by 460
Westerink, B. C., & Korf, J. (1976) · The Lancet · doi:10.1016/s0140-6736(76)90053-2 · Cited by 460
Novel histone deacetylase inhibitors in clinical trials as anti-cancer agents
Tan, J., Cang, S., Ma, Y., Petrillo, R. L., & Liu, D. (2010) · Journal of Hematology & Oncology · doi:10.1186/1756-8722-3-5 · Cited by 425
Samrén, E. B., van Duijn, C. M., Koch, S., Hiilesmaa, V. K., Klepel, H., Bardy, A. H., Mannagetta, G. B., Deichl, A. W., Gaily, E., Granström, I. L., et al. (1997) · Epilepsia · doi:10.1111/j.1528-1157.1997.tb01480.x · Cited by 406
Risk of Stevens–Johnson syndrome and toxic epidermal necrolysis in new users of antiepileptics
Mockenhaupt, M., Messenheimer, J., Tennis, P., & Schlingmann, J. (2005) · Neurology · doi:10.1212/01.wnl.0000156354.20227.f0 · Cited by 399
Valproate–Induced Hepatic Injury: Analyses of 23 Fatal Cases
Zimmerman, H. J., & Ishak, K. G. (1982) · Hepatology · doi:10.1002/hep.1840020513 · Cited by 393
The spectrum of clinical disease caused by the A467T and W748S POLG mutations: a study of 26 cases
Tzoulis, C. (2006) · Brain · doi:10.1093/brain/awl097 · Cited by 351
Rzany, B., Correia, O., Kelly, J. P., Naldi, L., Auquier, A., & Stern, R. (1999) · The Lancet · doi:10.1016/s0140-6736(98)05418-x · Cited by 348 · cited 1×
“difficult to identify VPA as the definitive causative drug [143,168].”
Anticonvulsant Hypersensitivity Syndrome: Incidence, Prevention and Management
Knowles, S. R., Shapiro, L. E., & Shear, N. H. (1999) · Drug Safety · doi:10.2165/00002018-199921060-00005 · Cited by 303
Molecular and clinical genetics of mitochondrial diseases due to POLG mutations
Wong, L.-J. C., Naviaux, R. K., Brunetti-Pierri, N., Zhang, Q., Schmitt, E. S., Truong, C., Milone, M., Cohen, B. H., Wical, B., Ganesh, J., et al. (2008) · Human Mutation · doi:10.1002/humu.20824 · Cited by 291
Glauser, T. A., Cnaan, A., Shinnar, S., Hirtz, D. G., Dlugos, D., Masur, D., Clark, P. O., Adamson, P. C., & for the Childhood Absence Epilepsy Study Team (2013) · Epilepsia · doi:10.1111/epi.12028 · Cited by 271
Levi, N., Bastuji-Garin, S., Mockenhaupt, M., Roujeau, J.-C., Flahault, A., Kelly, J. P., Martin, E., Kaufman, D. W., & Maison, P. (2009) · Pediatrics · doi:10.1542/peds.2008-1923 · Cited by 270
Wide, K., Winbladh, B., & Källén, B. (2004) · Acta Paediatrica · doi:10.1111/j.1651-2227.2004.tb00701.x · Cited by 264
Tennis, P., & Stern, R. S. (1997) · Neurology · doi:10.1212/wnl.49.2.542 · Cited by 261
Valproic acid and sodium valproate for neuropathic pain and fibromyalgia in adults
Gill, D., Derry, S., Wiffen, P. J., & Moore, R. A. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009183.pub2 · Cited by 253
Kesterson, J. W., Granneman, R. G., & Machinist, J. M. (1984) · Hepatology · doi:10.1002/hep.1840040609 · Cited by 250
Polymerase γ Gene POLG Determines the Risk of Sodium Valproate-Induced Liver Toxicity
Stewart, J. D., Horvath, R., Baruffini, E., Ferrero, I., Bulst, S., Watkins, P. B., Fontana, R. J., Day, C. P., & Chinnery, P. F. (2010) · Hepatology · doi:10.1002/hep.23891 · Cited by 241
Reye-like syndrome associated with valproic acid therapy
Gerber, N., Dickinson, R. G., Harland, R. C., Lynn, R. K., Houghton, D., Antonias, J. I., & Schimschock, J. C. (1979) · The Journal of Pediatrics · doi:10.1016/s0022-3476(79)80110-9 · Cited by 224
Valproic acid hepatic fatalities.: II. US experience since 1984
Dreifuss, F. E., Langer, D. H., Moline, K. A., & Maxwell, J. E. (1989) · Neurology · doi:10.1212/wnl.39.2.201 · Cited by 219
Effects of long‐term antiepileptic drug monotherapy on vascular risk factors and atherosclerosis
Chuang, Y., Chuang, H., Lin, T., Chang, C., Lu, C., Chang, W., Chen, S., Tan, T., Huang, C., & Chan, S. H. H. (2012) · Epilepsia · doi:10.1111/j.1528-1167.2011.03316.x · Cited by 217
Wang, Y., Xia, J., Helfer, B., Li, C., & Leucht, S. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004028.pub4 · Cited by 183
Why are antiepileptic drugs used for nonepileptic conditions?
Bialer, M. (2012) · Epilepsia · doi:10.1111/j.1528-1167.2012.03712.x · Cited by 174
POLG1 mutations cause a syndromic epilepsy with occipital lobe predilection
Engelsen, B. A., Tzoulis, C., Karlsen, B., Lillebo, A., Laegreid, L. M., Aasly, J., Zeviani, M., & Bindoff, L. A. (2008) · Brain · doi:10.1093/brain/awn007 · Cited by 168
Fetal exposure to teratogens: Evidence of genes involved in autism
Dufour-Rainfray, D., Vourc’h, P., Tourlet, S., Guilloteau, D., Chalon, S., & Andres, C. R. (2011) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2010.12.013 · Cited by 167
Fatal Liver Failure in 16 Children with Valproate Therapy
Scheffner, D., Konig, S., Rauterberg‐Ruland, I., Kochen, W., Hofmann, W. J., & Unkelbach, S. (1988) · Epilepsia · doi:10.1111/j.1528-1157.1988.tb03757.x · Cited by 163
Early cognitive development in children born to women with epilepsy: A prospective report
Bromley, R. L., Mawer, G., Love, J., Kelly, J., Purdy, L., McEwan, L., Briggs, M., Smith, J. C., Sin, X., & Baker, G. A. (2010) · Epilepsia · doi:10.1111/j.1528-1167.2010.02668.x · Cited by 161
Van Goethem, G., Schwartz, M., Löfgren, A., Dermaut, B., Van Broeckhoven, C., & Vissing, J. (2003) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5201002 · Cited by 161
Chan, S. S. L., Longley, M. J., & Copeland, W. C. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m506762200 · Cited by 155
Sasarman, F., Antonická, H., & Shoubridge, E. A. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddn265 · Cited by 153
ATTEMPTED SUICIDE WITH PURIFIED AFLATOXIN
Willis, R., Mulvihill, J., & Hoofnagle, J. (1980) · The Lancet · doi:10.1016/s0140-6736(80)91665-7 · Cited by 152
Vainionpää, L. K., Mikkonen, K. H., Rättyä, J., Knip, M., Pakarinen, A., Myllylä, V. V., & Isojärvi, J. I. T. (2004) · Epilepsia · doi:10.1111/j.0013-9580.2004.26003.x · Cited by 150
Bondon‐Guitton, E., Perez‐Lloret, S., Bagheri, H., Brefel‐Courbon, C., Rascol, O., & Montastruc, J. (2011) · Movement Disorders · doi:10.1002/mds.23828 · Cited by 149
A review of valproate in psychiatric practice
Haddad, P. M., Das, A. K., Ashfaq, M., & Wieck, A. (2009) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425250902911455 · Cited by 148
Molecular diagnosis of Alpers syndrome
Nguyen, K. V., Sharief, F. S., Chan, S. S. L., Copeland, W. C., & Naviaux, R. K. (2006) · Journal of Hepatology · doi:10.1016/j.jhep.2005.12.026 · Cited by 146
The metabolic syndrome in overweight epileptic patients treated with valproic acid
Verrotti, A., Manco, R., Agostinelli, S., Coppola, G., & Chiarelli, F. (2009) · Epilepsia · doi:10.1111/j.1528-1167.2009.02206.x · Cited by 142
Saneto, R. P., Lee, I.-C., Koenig, M. K., Bao, X., Weng, S., Naviaux, R. K., & Wong, L.-J. C. (2010) · Seizure · doi:10.1016/j.seizure.2010.01.002 · Cited by 142
Foetal malformations and seizure control: 52 months data of the Australian Pregnancy Registry
Vajda, F. J. E., Hitchcock, A. A., Graham, J. E., Solinas, C., O'Brien, T. J., Lander, C. M., & Eadie, M. J. (2006) · European Journal of Neurology · doi:10.1111/j.1468-1331.2006.01359.x · Cited by 141
Effects of breastfeeding in children of women taking antiepileptic drugs
Meador, K. J., Baker, G. A., Browning, N., Clayton‐Smith, J., Combs‐Cantrell, D. T., Cohen, M. J., Kalayjian, L. A., Kanner, A. M., Liporace, J. D., Pennell, P. B., et al. (2010) · Neurology · doi:10.1212/wnl.0b013e3181ffe4a9 · Cited by 141
Pregnancy, delivery, and outcome for the child in maternal epilepsy
Veiby, G., Daltveit, A. K., Engelsen, B. A., & Gilhus, N. E. (2009) · Epilepsia · doi:10.1111/j.1528-1167.2009.02147.x · Cited by 141
Eriksson, K. J., Viinikainen, K., Mönkkönen, A., Äikiä, M., Nieminen, P., Heinonen, S. T., & Kälviäinen, R. K. (2005) · Epilepsy Research · doi:10.1016/j.eplepsyres.2005.06.001 · Cited by 139
Use of Antiepileptic Medications in Pregnancy in Relation to Risks of Birth Defects
Werler, M. M., Ahrens, K. A., Bosco, J. L. F., Mitchell, A. A., Anderka, M., Gilboa, S. M., & Holmes, L. B. (2011) · Annals of Epidemiology · doi:10.1016/j.annepidem.2011.08.002 · Cited by 139
Marcus, R. N., Khan, A., Rollin, L., Morris, B. A., Timko, K., Carson, W. H., & Sanchez, R. (2011) · Bipolar Disorders · doi:10.1111/j.1399-5618.2011.00898.x · Cited by 139
Adverse events with use of antiepileptic drugs: a prescription and event symmetry analysis
Tsiropoulos, I., Andersen, M. T., & Hallas, J. (2009) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1736 · Cited by 138
Antiepileptic drugs and pregnancy outcomes
Wlodarczyk, B. J., Palacios, A. M., George, T. M., & Finnell, R. H. (2012) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.35438 · Cited by 138
The Spectrum of Hepatotoxicity
Zimmerman, H. J. (1968) · Perspectives in biology and medicine · doi:10.1353/pbm.1968.0004 · Cited by 134
Trost, L. C., & Lemasters, J. J. (1996) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)20745-5 · Cited by 131
POLG mutations and Alpers syndrome
Davidzon, G., Mancuso, M., Ferraris, S., Quinzii, C. M., Hirano, M., Peters, H. L., Kirby, D. M., Thorburn, D. R., & DiMauro, S. (2005) · Annals of Neurology · doi:10.1002/ana.20498 · Cited by 130
Structure–function studies for the panacea, valproic acid
Terbach, N., & Williams, R. S. B. (2009) · Biochemical Society Transactions · doi:10.1042/bst0371126 · Cited by 127
Sodium valproate for painful diabetic neuropathy: a randomized double-blind placebo-controlled study
Kochar, D. K., Rawat, N., Agrawal, R. P., Vyas, A., Beniwal, R., Kochar, S. K., & Garg, P. (2003) · QJM · doi:10.1093/qjmed/hch007 · Cited by 127
Incidence, Severity, and Etiology of Drug-Induced Acute Pancreatitis
Vinklerová, I., Procházka, M., Procházka, V., & Urbánek, K. (2010) · Digestive Diseases and Sciences · doi:10.1007/s10620-010-1277-3 · Cited by 123
Mitochondrial toxicity of antiepileptic drugs and their tolerability in mitochondrial disorders
Finsterer, J., & Zarrouk‐Mahjoub, S. (2011) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2012.644535 · Cited by 120
Lam, C. W., Lau, C. H., Williams, J., Chan, Y., & Wong, L. J. (1997) · European Journal of Pediatrics · doi:10.1007/s004310050663 · Cited by 118
Aires, C. C. P., van Cruchten, A. G., IJlst, L., de Almeida, I. T., Durán, M., Wanders, R. J. A., & Silva, M. F. B. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.11.031 · Cited by 116
Severe cutaneous adverse reactions to antiepileptic drugs in Asians
Yang, C., Dao, R., Lee, T.-J., Lu, C., Yang, C., Chung, W., & Chung, W. (2011) · Neurology · doi:10.1212/wnl.0b013e31823b478c · Cited by 115
Mitochondrial diseases represent a risk factor for valproate‐induced fulminant liver failure
Krähenbühl, S., Brandner, S., Kleinle, S., Liechti, S., & Straumann, D. (2000) · Liver International · doi:10.1034/j.1600-0676.2000.020004346.x · Cited by 115
Antiepileptic Drugs and Markers of Vascular Risk
LoPinto‐Khoury, C., & Mintzer, S. (2010) · Current Treatment Options in Neurology · doi:10.1007/s11940-010-0080-y · Cited by 115
A meta-analysis of polycystic ovary syndrome in women taking valproate for epilepsy
Hu, X., Wang, J., Dong, W., Fang, Q., Hu, L., & Liu, C. (2011) · Epilepsy Research · doi:10.1016/j.eplepsyres.2011.07.006 · Cited by 111
Antiepileptic drugs, sex hormones, and PCOS
Verrotti, A., D’Egidio, C., Mohn, A., Coppola, G., Parisi, P., & Chiarelli, F. (2011) · Epilepsia · doi:10.1111/j.1528-1167.2010.02897.x · Cited by 108
Chopra, A., Kolla, B. P., Mansukhani, M. P., Netzel, P. J., & Frye, M. A. (2012) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2011.12.009 · Cited by 107
Soares‐Weiser, K., Vergel, Y. B., Beynon, S., Dunn, G., Barbieri, M., Duffy, S., Geddes, J. R., Gilbody, S. M., Palmer, S., & Woolacott, N. F. (2007) · Health Technology Assessment · doi:10.3310/hta11390 · Cited by 107
Polycystic ovary syndrome in women using valproate: A review
Bilo, L., & Meo, R. (2008) · Gynecological Endocrinology · doi:10.1080/09513590802288259 · Cited by 106
Banach, R., Boskovic, R., Einarson, T., & Koren, G. (2010) · Drug Safety · doi:10.2165/11317640-000000000-00000 · Cited by 105
Nadebaum, C., Anderson, V. A., Vajda, F. J. E., Reutens, D. C., Barton, S., & WOOD, A. G. (2010) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617710001359 · Cited by 105
Hepatic Considerations in the Use of Antiepileptic Drugs
Dreifuss, F. E., & Langer, D. H. (1987) · Epilepsia · doi:10.1111/j.1528-1157.1987.tb05768.x · Cited by 104
Thyroid Adverse Effects of Psychotropic Drugs: A Review
Khalil, R. B., & Richa, S. (2011) · Clinical Neuropharmacology · doi:10.1097/wnf.0b013e31823429a7 · Cited by 102
Verrotti, A., Laus, M., Scardapane, A., Franzonı, E., & Chiarelli, F. (2008) · European Journal of Endocrinology · doi:10.1530/eje-08-0325 · Cited by 100
The teratogenic risk of antiepileptic drug polytherapy
Vajda, F. J. E., Hitchcock, A. A., Graham, J. E., O'Brien, T. J., Lander, C. M., & Eadie, M. J. (2009) · Epilepsia · doi:10.1111/j.1528-1167.2009.02336.x · Cited by 98
Chan, S. S. L., Longley, M. J., & Copeland, W. C. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl424 · Cited by 98
Luef, G. J., Rauchenzauner, M., Waldmann, M., Sturm, W., Sandhofer, A., Seppi, K., Trinka, E., Unterberger, I., Ebenbichler, C. F., Joannidis, M., et al. (2009) · Epilepsy Research · doi:10.1016/j.eplepsyres.2009.04.004 · Cited by 94
Drugs interfering with mitochondrial disorders
Finsterer, J., & Segall, L. (2009) · Drug and Chemical Toxicology · doi:10.3109/01480540903207076 · Cited by 92
MELAS ASSOCIATED WITH MUTATIONS IN THE POLG1 GENE
Deschauer, M., Tennant, S., Rokicka, A., He, L., Kraya, T., Turnbull, D. M., Zierz, S., & Taylor, R. W. (2007) · Neurology · doi:10.1212/01.wnl.0000261929.92478.3e · Cited by 92
Valproate–Induced Hepatic Steatogenesis in Rats
Lewis, J. H., Zimmerman, H. J., Garrett, C. T., & Rosenberg, E. (1982) · Hepatology · doi:10.1002/hep.1840020622 · Cited by 90
Decreased serum carnitine in valproate induced Reye syndrome
B�hles, H. J., Richter, K. D., Wagner-Thiessen, E., & Sch�fer, H. (1982) · European Journal of Pediatrics · doi:10.1007/bf01377353 · Cited by 90
The Tolerability of Lamotrigine in Children
Messenheimer, J. A., Giorgi, L., & Risner, M. E. (2000) · Drug Safety · doi:10.2165/00002018-200022040-00003 · Cited by 90
Lamotrighe‐Induced Severe Cutaneous Adverse Reactions
Schlienger, R. G., Shapiro, L. E., & Shear, N. H. (1998) · Epilepsia · doi:10.1111/j.1528-1157.1998.tb01681.x · Cited by 89
L-Carnitine for Acute Valproic Acid Overdose: A Systematic Review of Published Cases
Perrott, J., Murphy, N. G., & Zed, P. J. (2010) · Annals of Pharmacotherapy · doi:10.1345/aph.1p135 · Cited by 89
Valproic acid as a promising agent to combat Alzheimer's disease
Zhang, X., Li, X., & Zhang, H. (2009) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2009.09.003 · Cited by 86
Uusimaa, J., Hinttala, R., Rantala, H., Päivärinta, M., Herva, R., Röyttä, M., Soini, H. K., Moilanen, J. S., Remes, A. M., Hassinen, I. E., et al. (2008) · Epilepsia · doi:10.1111/j.1528-1167.2008.01544.x · Cited by 84
Sodium Valproate in the Induction of Unusual Hepatotoxicity
Zafrani, É. S., & Berthelot, P. (1982) · Hepatology · doi:10.1002/hep.1840020520 · Cited by 82
Epilepsy in mitochondrial disorders
Finsterer, J., & Zarrouk‐Mahjoub, S. (2012) · Seizure · doi:10.1016/j.seizure.2012.03.003 · Cited by 81
Valproate-Induced Insulin Resistance and Obesity in Children
Verrotti, A., la Torre, R., Trotta, D., Mohn, A., & Chiarelli, F. (2009) · Hormone Research in Paediatrics · doi:10.1159/000197868 · Cited by 80
Valproic Acid in Epilepsy: Pregnancy-Related Issues
Genton, P., Semah, F., & Trinka, E. (2006) · Drug Safety · doi:10.2165/00002018-200629010-00001 · Cited by 79
Gastrointestinal adverse effects of antiepileptic drugs in intractable epileptic patients
Jahromi, S. R., Togha, M., Fesharaki, S. H., Najafi, M., Moghadam, N. B., Kheradmand, J. A., Kazemi, H., & Gorji, A. (2011) · Seizure · doi:10.1016/j.seizure.2010.12.011 · Cited by 79
A novel lymphocyte toxicity assay to assess drug hypersensitivity syndromes
Neuman, M. G., Malkiewicz, I. M., & Shear, N. H. (2000) · Clinical Biochemistry · doi:10.1016/s0009-9120(00)00146-6 · Cited by 75
Self-citationHematological Effects of Valproate in Psychiatric Patients: What Are the Risk Factors?
Vasudev, K., Keown, P., Gibb, I., & McAllister-Williams, H. (2010) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e3181db2684 · Cited by 70
Efficacy of valproate versus lithium in mania or mixed mania: a randomized, open 12-week trial
Bowden, C. L., Mosolov, S. N., Hranov, L. G., Chen, E. Y. H., Habil, H., Kongsakon, R., Manfredi, R., & Lin, H.-N. (2010) · International Clinical Psychopharmacology · doi:10.1097/yic.0b013e328333ac1b · Cited by 70
Changing patterns of antiepileptic drug use in pregnant Australian women
Vajda, F. J. E., Hollingworth, S., Graham, J. E., Hitchcock, A. A., O’Brien, T. J., Lander, C. M., & Eadie, M. J. (2009) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2009.01260.x · Cited by 67
Ferrajolo, C., Capuano, A., Verhamme, K. M. C., Schuemie, M. J., Rossi, F., Stricker, B. H. C., & Sturkenboom, M. (2010) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2010.03754.x · Cited by 67
Reversible valproate hepatotoxicity due to mutations in mitochondrial DNA polymerase γ ( POLG1 )
McFarland, R., Hudson, G., Taylor, R. W., Green, S. H., Hodges, S., McKiernan, P. J., Chinnery, P. F., & Ramesh, V. (2008) · Archives of Disease in Childhood · doi:10.1136/adc.2007.122911 · Cited by 66
The role of valproate in metabolic disturbances in bipolar disorder patients
Chang, H. H., Yang, Y. K., Gean, P. W., Huang, H. C., Chen, P. S., & Lu, R. B. (2010) · Journal of Affective Disorders · doi:10.1016/j.jad.2009.12.011 · Cited by 66
McVearry, K. M., Gaillard, W. D., VanMeter, J. W., & Meador, K. J. (2009) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2009.09.024 · Cited by 66
Zeng, K., Wang, X., Xi, Z., & Yan, Y. (2010) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2009.12.014 · Cited by 66
VALPROIC ACID ASSOCIATED ABNORMALITIES OF CARNITINE METABOLISM
Murphy, J., Marquardt, K. M., & Shug, A. (1985) · The Lancet · doi:10.1016/s0140-6736(85)91481-3 · Cited by 64
CYP2E1-mediated modulation of valproic acid-induced hepatocytotoxicity
Neuman, M. G., Shear, N. H., Jacobson-Brown, P., Katz, G. G., Neilson, H. K., Malkiewicz, I. M., Cameron, R., & Abbott, F. S. (2001) · Clinical Biochemistry · doi:10.1016/s0009-9120(01)00217-x · Cited by 63
Self-citationChanging trends in antiepileptic drug prescribing in girls of child-bearing potential
Ackers, R., Besag, F., Wade, A. M., Murray, M. L., & Wong, I. C. K. (2009) · Archives of Disease in Childhood · doi:10.1136/adc.2008.144386 · Cited by 63
Schwarz, C. J., Volz, A., Li, C., & Leucht, S. (2008) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004028.pub3 · Cited by 63
Li, L. M., Russo, M., O’Donoghue, M., Duncan, J. S., & Sander, J. W. A. S. (1996) · Arquivos de Neuro-Psiquiatria · doi:10.1590/s0004-282x1996000100008 · Cited by 61
Fatal reye‐like syndrome associated with valproic acid
Young, R. S. K., Bergman, I., Gang, D. L., & Richardson, E. P. (1980) · Annals of Neurology · doi:10.1002/ana.410070423 · Cited by 61
Valproic Acid–Induced Parkinsonism in the Elderly: A Comprehensive Review of the Literature
Mahmoud, F. A., & Tampi, R. R. (2011) · The American Journal of Geriatric Pharmacotherapy · doi:10.1016/j.amjopharm.2011.09.002 · Cited by 60
Elmslie, J. L., Porter, R., Joyce, P. R., Hunt, P. J., Shand, B. I., & Scott, R. S. (2009) · Australian & New Zealand Journal of Psychiatry · doi:10.1080/00048670802534341 · Cited by 59
Kasiviswanathan, R., Longley, M. J., Chan, S. S. L., & Copeland, W. C. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.011940 · Cited by 57
Ibuprofen-induced hypersensitivity syndrome
Nanau, R. M., & Neuman, M. G. (2010) · Translational research · doi:10.1016/j.trsl.2010.01.005 · Cited by 56
Self-citationKiang, T. K. L., Teng, X. W., Surendradoss, J., Karagiozov, S. K., Abbott, F. S., & Chang, T. K. H. (2011) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2011.03.004 · Cited by 55
Kiang, T. K. L., Teng, X. W., Karagiozov, S. K., Surendradoss, J., Chang, T. K. H., & Abbott, F. S. (2010) · Toxicological Sciences · doi:10.1093/toxsci/kfq294 · Cited by 55
Yamada, M., & Welty, T. E. (2011) · Annals of Pharmacotherapy · doi:10.1345/aph.1q349 · Cited by 55
Valproate-Induced Hyperammonemic Encephalopathy and Normal Liver Functions
Deutsch, S. I., Burket, J. A., & Rosse, R. B. (2009) · Clinical Neuropharmacology · doi:10.1097/wnf.0b013e3181ac3615 · Cited by 54
Safety of long-term treatment of HAM/TSP patients with valproic acid
Olindo, S., Belrose, G., Gillet, N., Rodriguez, S., Boxus, M., Verlaeten, O., Asquith, B., Bangham, C., Signaté, A., Smadja, D., et al. (2011) · Blood · doi:10.1182/blood-2011-04-349910 · Cited by 52
Pharmacological Synergy: The Next Frontier on Therapeutic Advancement for Migraine
Blumenfeld, A. M., Gennings, C., & Cady, R. K. (2012) · Headache The Journal of Head and Face Pain · doi:10.1111/j.1526-4610.2011.02058.x · Cited by 51
Novel POLG1 mutations associated with neuromuscular and liver phenotypes in adults and children
Stewart, J. D., Tennant, S., Powell, H., Pyle, A., Blakely, E. L., He, L., Hudson, G., Roberts, M., du Plessis, D., Gow, D. E., et al. (2009) · Journal of Medical Genetics · doi:10.1136/jmg.2008.058180 · Cited by 51
Barreto, S. G., Tiong, L. U., & Williams, R. (2011) · PubMed · doi:10.6092/1590-8577/491 · Cited by 50
Euro, L., Farnum, G. A., Palin, E., Suomalainen, A., & Kaguni, L. S. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkr618 · Cited by 49
Hormonal and reproductive disturbances in epileptic male patients: Emerging issues
Verrotti, A., Loiacono, G., Laus, M., Coppola, G., Chiarelli, F., & Tiboni, G. M. (2011) · Reproductive Toxicology · doi:10.1016/j.reprotox.2011.02.002 · Cited by 49
Erdemir, A., Çullu, N., Yiş, U., Demircioğlu, F., Kır, M., Çakmakçı, H., Ünal, N., & Dırık, E. (2008) · Brain and Development · doi:10.1016/j.braindev.2008.11.001 · Cited by 49
Lossius, M. I., Taubøll, E., Mowinckel, P., & Gjerstad, L. (2009) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2009.07.014 · Cited by 48
Clonally Expanded Mitochondrial DNA Mutations in Epileptic Individuals With Mutated DNA Polymerase γ
Zsurka, G., Baron, M., Stewart, J. D., Kornblum, C., Bös, M., Sassen, R., Taylor, R. W., Elger, C. E., Chinnery, P. F., & Kunz, W. S. (2008) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3181839b2d · Cited by 48
Rahman, A., Mican, L. M., Fischer, C., et al. (2009) · Annals of Pharmacotherapy · doi:10.1345/aph.1l617 · Cited by 45
Neuman, M. G., Malkiewicz, I. M., Phillips, E. J., Rachlis, A., Ong, D., Yeung, E., & Shear, N. H. (2002) · Therapeutic Drug Monitoring · doi:10.1097/00007691-200212000-00008 · Cited by 43
Self-citationChoice of antiepileptic drugs for the elderly: possible drug interactions and adverse effects
Јаnkovic, S., & Dostic, M. (2011) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2012.645535 · Cited by 43
Lisi, A., Botto, L. D., Robert‐Gnansia, E., Castilla, E. E., Bakker, M. K., Bianca, S., Cocchi, G., Vigan, C. D., Dutra, M. D. G., Horáček, J., et al. (2010) · Reproductive Toxicology · doi:10.1016/j.reprotox.2010.03.005 · Cited by 42
Fanconi Syndrome Caused by Valproic Acid
Endo, A., Fujita, Y., Fuchigami, T., Takahashi, S., & Mugishima, H. (2010) · Pediatric Neurology · doi:10.1016/j.pediatrneurol.2009.12.003 · Cited by 42
Hamed, S. A., & Abdella, M. M. (2009) · Epilepsy Research · doi:10.1016/j.eplepsyres.2009.04.002 · Cited by 41
Effect of long-term valproate monotherapy on bone mineral density in adults with epilepsy
Triantafyllou, N. I., Lambrinoudaki, I., Armeni, E., Evangelopoulos, M., Boufidou, F., Antoniou, A., & Tsivgoulis, G. K. (2010) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2009.12.015 · Cited by 41
Antiepileptic Drug-Induced Hypersensitivity Syndrome Reactions
Krivoy, N., Taer, M., & Neuman, M. G. (2006) · Current Drug Safety · doi:10.2174/157488606777934459 · Cited by 41
Self-citationNonalcoholic fatty liver disease in adolescents receiving valproic acid
Verrotti, A., Agostinelli, S., Parisi, P., Chiarelli, F., & Coppola, G. (2011) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2010.12.012 · Cited by 40
Pritchett, J. C., Nanau, R. M., & Neuman, M. G. (2012) · International Journal of Hepatology · doi:10.1155/2012/723062 · Cited by 39
Self-citationSchaller, A., Hahn, D., Jackson, C. B., Kern, I., Chardot, C., Belli, D. C., Gallati, S., & Nuoffer, J. (2011) · BMC Neurology · doi:10.1186/1471-2377-11-4 · Cited by 39
Weight Gain and Insulin Resistance in Children Treated With Valproate: The Influence of Time
Masuccio, F. G., Verrotti, A., Chiavaroli, V., de Giorgis, T., Giannini, C., Chiarelli, F., & Mohn, A. (2010) · Journal of Child Neurology · doi:10.1177/0883073809349461 · Cited by 38
Reye-like syndrome associated with valproic acid
Sugimoto, T., Nishida, N., Yasuhara, A., Ono, A., Sakane, Y., & Matsumura, T. (1983) · Brain and Development · doi:10.1016/s0387-7604(83)80029-1 · Cited by 36
Grosso, S., Mostardini, R., Piccini, B., et al. (2008) · Annals of Pharmacotherapy · doi:10.1345/aph.1l414 · Cited by 36
Cameron, R., Feuer, G. M., & de la Iglesia, F. A. (1996) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-61013-4 · Cited by 36
Drug Prescribing Before and During Pregnancy in South West France
Crespin, S., Bourrel, R., Hurault‐Delarue, C., et al. (2011) · Drug Safety · doi:10.2165/11589170-000000000-00000 · Cited by 35
Sahu, J. K., Gulati, S., Kabra, M., Arya, R., Sharma, R., Gupta, N., Kaleekal, T., Reeta, K. H., & Gupta, Y. K. (2011) · Journal of Child Neurology · doi:10.1177/0883073811421985 · Cited by 35
Modification in body weight associated with antiepileptic drugs
de Gaspari, C. N., & Guerreiro, C. A. M. (2010) · Arquivos de Neuro-Psiquiatria · doi:10.1590/s0004-282x2010000200024 · Cited by 35
Gilboa, S. M., Broussard, C. S., Devine, O. J., Duwe, K. N., Pennington, A. F., Boulet, S. L., Moore, C. A., Werler, M. M., & Honein, M. A. (2011) · American Journal of Medical Genetics Part C Seminars in Medical Genetics · doi:10.1002/ajmg.c.30306 · Cited by 34
Lamotrigine-associated anticonvulsant hypersensitivity syndrome in bipolar disorder
Chang, C.-C., Shiah, I., Yeh, C., Wang, T., & Chang, H. (2006) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2005.11.033 · Cited by 33
Postural induced‐tremor in psychiatry
Arbaizar, B., Gómez‐Acebo, I., & Llorca, J. (2008) · Psychiatry and Clinical Neurosciences · doi:10.1111/j.1440-1819.2008.01877.x · Cited by 33
Medium chain acyl-CoA dehydrogenase deficiency and fatal valproate toxicity
Njølstad, P. R., Skjeldal, O. H., Agsteribbe, E., Huckriede, A. L. W., Wannag, E., Sövik, O., & Waaler, P. E. (1997) · Pediatric Neurology · doi:10.1016/s0887-8994(96)00318-9 · Cited by 33
Novel POLG Splice Site Mutation and Optic Atrophy
Milone, M., Wang, J., Liewluck, T., Chen, L.-C., Leavitt, J. A., & Wong, L.-J. C. (2011) · Archives of Neurology · doi:10.1001/archneurol.2011.124 · Cited by 33
Immunopathogenesis of hypersensitivity syndrome reactions to sulfonamides
Neuman, M. G., Shear, N. H., Malkiewicz, I. M., Taeri, M., Shapiro, L. E., Krivoy, N., Haber, J. A., Gómez, M., Fish, J. S., Cartotto, R. C., et al. (2007) · Translational research · doi:10.1016/j.trsl.2006.12.001 · Cited by 32
Self-citationHyperammonemia following intravenous valproate loading
DeWolfe, J. L., Knowlton, R. C., Beasley, T. M., et al. (2009) · Epilepsy Research · doi:10.1016/j.eplepsyres.2009.02.012 · Cited by 32
Genetic and Immune Predictors for Hypersensitivity Syndrome to Antiepileptic DrugsPreprint
Neuman, M. G., Cohen, L. B., Nanau, R. M., & Hwang, P. A. (2011) · Nature Precedings · doi:10.1016/j.trsl.2012.01.004 · Cited by 32
Self-citationThyroid Hormones in Children on Antiepileptic Therapy
Aygün, F., Ekici, B., Aydınli̇, N., Aydın, B. K., Baş, F., & Tatlı, B. (2011) · International Journal of Neuroscience · doi:10.3109/00207454.2011.627486 · Cited by 32
Simonati, A., Filosto, M., Savio, C., Tomelleri, G., Tonin, P., Bernardina, B. D., & Rizzuto, N. (2003) · Acta Neuropathologica · doi:10.1007/s00401-003-0698-x · Cited by 31
Thyroid Hormone Levels in Children Receiving Carbamazepine or Valproate
Aggarwal, A., Rastogi, N., Mittal, H. G., Chillar, N., & Patil, R. (2011) · Pediatric Neurology · doi:10.1016/j.pediatrneurol.2011.04.005 · Cited by 30
Yıldız, M., Şimşek, G., Uzun, H., Uysal, S., Şahin, S., & Balcı, H. (2010) · Cardiology in the Young · doi:10.1017/s1047951110000697 · Cited by 30
Cheng, L. S., Prasad, A. N., & Rieder, M. J. (2010) · PubMed · Cited by 30
Apoptosis in ibuprofen-induced Stevens–Johnson syndrome
Neuman, M. G., & Nicar, M. J. (2007) · Translational research · doi:10.1016/j.trsl.2006.12.005 · Cited by 28
Self-citationHalevy, S., & Grossman, N. (2008) · PubMed · Cited by 28
Chang, H. H., Gean, P. W., Chou, C. H., Yang, Y. K., Tsai, H. C., Lu, R. B., & Chen, P. S. (2010) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e3181f03f50 · Cited by 27
Nonalcoholic fatty liver disease during valproate therapy
Verrotti, A., Marco, G. D., la Torre, R., Pelliccia, P., & Chiarelli, F. (2009) · European Journal of Pediatrics · doi:10.1007/s00431-009-0927-y · Cited by 27
Effect of CPS14217C>A genotype on valproic‐acid‐induced hyperammonemia
Yagi, M., Nakamura, T., Okizuka, Y., et al. (2010) · Pediatrics International · doi:10.1111/j.1442-200x.2010.03157.x · Cited by 27
Stevens-Johnson Syndrome Due to Concomitant Use of Lamotrigine and Valproic Acid
Koçak, S., Girisgin, S. A., Gül, M., Cander, B., Kaya, H., & Kaya, E. (2007) · American Journal of Clinical Dermatology · doi:10.2165/00128071-200708020-00007 · Cited by 26
Mehndiratta, M. M., Mehndiratta, P., Phul, P., & Garg, S. (2008) · PubMed · Cited by 26
Surendradoss, J., Chang, T. K. H., & Abbott, F. S. (2012) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2012.08.018 · Cited by 25
Valproic Acid-Associated Vanishing Bile Duct Syndrome
Gökçe, S., Durmaz, Ö., Çeltık, C., Aydoğan, A., GULLUOGLU, M. G., & Sökücü, S. (2010) · Journal of Child Neurology · doi:10.1177/0883073809343474 · Cited by 25
Valproic acid utilizes the isoleucine breakdown pathway for its complete β-oxidation
Luis, P. B., Ruiter, J. P. N., Ofman, R., IJlst, L., Moedas, M. F., Diogo, L. M., Garcia, P., de Almeida, I. T., Durán, M., Wanders, R. J. A., et al. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.07.103 · Cited by 25
Acquired von Willebrand syndrome as side effect of valproic acid therapy in children is rare
Budde, U., Bentele, K. H. P., Christen, H. ‐., Knapp, R., Mey, A., Schneppenheim, R., & Eberl, W. (2009) · Hämostaseologie · doi:10.1055/s-0037-1617026 · Cited by 24
Tubulo-interstitial nephritis caused by sodium valproate
Yoshikawa, H., Watanabe, T., & Abe, T. (2002) · Brain and Development · doi:10.1016/s0387-7604(02)00007-4 · Cited by 23
Özkan, H., Çetınkaya, M., Köksal, N., & Yapıcı, Ş. (2011) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.3109/14767058.2010.501120 · Cited by 23
Valproate Prescription Prevalence Among Women of Childbearing Age
Wisner, K. L., Leckman‐Westin, E., Finnerty, M. T., & Essock, S. M. (2011) · Psychiatric Services · doi:10.1176/ps.62.2.pss6202_0218 · Cited by 23
Toxic epidermal necrolysis with combination lamotrigine and valproate in bipolar disorder
Chang, C.-C., Shiah, I., Chang, H., & Huang, S. (2005) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2005.08.025 · Cited by 22
Alpers syndrome with prominent white matter changes
Bao, X., Wu, Y., Wong, L. C., Zhang, Y., Xiong, H., Chou, P., Truong, C. K., Jiang, Y., Qin, J., Yuan, Y., et al. (2007) · Brain and Development · doi:10.1016/j.braindev.2007.08.009 · Cited by 21
Jerrell, J., Bacon, J., Burgis, J., & Menon, S. (2009) · Journal of Adolescent Health · doi:10.1016/j.jadohealth.2008.11.010 · Cited by 21
Ghozzi, H., Hakim, A., Sahnoun, Z., Mahmoud, L. B., Atheymen, R., Hammami, S., & Zeghal, K. M. (2011) · Revue Neurologique · doi:10.1016/j.neurol.2011.02.035 · Cited by 20
Valproic acid-induced encephalopathy in very long course treated patients
Rousseau, M., Montana, M., Villano, P., Catala, A. R., Blaya, J., Valkov, M., Allouard, Y., & Bugni, E. (2009) · Brain Injury · doi:10.3109/02699050903302344 · Cited by 20
Mitochondrial DNA depletion in progressive external ophthalmoplegia caused byPOLG1mutations
Tzoulis, C., Papingji, M., Fiskestrand, T., Røste, L. S., & Bindoff, L. A. (2009) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2009.01212.x · Cited by 17
Fetal valproate syndrome in a 2-month-old male infant
Zaki, S. A., Phulsundar, A., Shanbag, P., & Mauskar, A. V. (2010) · Annals of Saudi Medicine · doi:10.4103/0256-4947.62839 · Cited by 16
A case of fetal valproate syndrome with new features expanding the phenotype
Seidahmed, M. Z., Miqdad, A. M., Dohami, H., & Shareefi, O. M. (2009) · Saudi Medical Journal · doi:10.15537/1658-3175.4638 · Cited by 16
Mitochondrial function and pathology in status epilepticus
Bindoff, L. A. (2011) · Epilepsia · doi:10.1111/j.1528-1167.2011.03223.x · Cited by 15
Abreu, L. N., Issler, C., & Lafer, B. (2009) · Australian & New Zealand Journal of Psychiatry · doi:10.1080/00048670902821606 · Cited by 15
Neyns, B., Hoorens, A., & Stupp, R. (2008) · PubMed · Cited by 14
Regulation of kidney development by histone deacetylases
Rosenberg, S. L., Chen, S. W., McLaughlin, N., & El-Dahr, S. S. (2011) · Pediatric Nephrology · doi:10.1007/s00467-011-1796-y · Cited by 13
Decreased thyroid function in Korean women with bipolar disorder receiving valproic acid
Park, Y. M., Kang, S., Lee, B.-H., & Lee, H. (2011) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2010.11.008 · Cited by 13
The real mechanism of VPA-induced hyperammonemia remains unknown
Hung, C.-C., Li, T., Wei, I., & Huang, C. (2010) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2010.10.004 · Cited by 12
Palin, E., Lesonen, A., Farr, C. L., Euro, L., Suomalainen, A., & Kaguni, L. S. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2010.02.003 · Cited by 12
Effects of adjunct valproic acid on clinical symptoms and saccadic eye movements in schizophrenia
Larrison, A. L., Babin, S. L., Yuan, X., Patel, S. S., Wassef, A. A., & Sereno, A. B. (2011) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.1236 · Cited by 11
HETEROZYGOUS α1-ANTITRYPSIN DEFICIENCY AND VALPROATE HEPATOTOXICITY
Moore, J. R., Williams, T., Talbot, I. C., & Tanner, M. S. (1984) · The Lancet · doi:10.1016/s0140-6736(84)92139-1 · Cited by 11
Clinical alertness to valproic acid-induced hyperammonemia-two case reports
Shan, J., Hsieh, M. H., Cc, L., Cc, W., & Liu, C. (2009) · Journal of Psychopharmacology · doi:10.1177/0269881109102635 · Cited by 10
Bipolar Disorder and Valproate-Induced Hyperammonemic Encephalopathy in an Adolescent with Diabetes
Young, L., & Coffey, B. J. (2010) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2010.2052 · Cited by 9
Antiepileptic drugs and breastfeeding
Klein, A. (2010) · Neurology · doi:10.1212/wnl.0b013e3181ff94d5 · Cited by 8
Fungal pleural effusion secondary to a rare cause of pancreatic pseudocyst
Gupta, A. K., Marrs, T., Urquhart, D. S., Clarke, S. A., Rosenthal, M., & Bush, A. (2009) · Pediatric Pulmonology · doi:10.1002/ppul.20982 · Cited by 6
MELAS syndrome associated with both A3243G-tRNALeu mutation and multiple mitochondrial DNA deletions
Aharoni, S., Traves, T. A., Melamed, E., Cohen, S., & Leshinsky‐Silver, E. (2010) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2010.06.029 · Cited by 6
Chang, L., Chang, H. W., & Lin, Y. (2012) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e31823f87e5 · Cited by 6
Valproate in acute mania: is our practice evidence based?
Vasudev, K., Mead, A., Macritchie, K., & Young, A. H. (2012) · International Journal of Health Care Quality Assurance · doi:10.1108/09526861211192395 · Cited by 6
[Valproate induced hypoactive delirium in a bipolar disorder patient with psychotic features].
Özen, Ş., Bülbül, İ., & Soyuçok, E. (2010) · PubMed · Cited by 6
Cognitive outcome after exposure to antiepileptic drugs in utero
Battino, D. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70154-1 · Cited by 5
Hyperammoneic Encephalopathy, Valproic Acid, and Benzodiazepine Withdrawal: A Case Series
Starer, J., & Chang, G. (2010) · The American Journal of Drug and Alcohol Abuse · doi:10.3109/00952991003674804 · Cited by 5
Valproic acid: long-term effects on children exposed in utero.
(2009) · PubMed · Cited by 2
Israel, Y., & Rubin, E. (1996) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-61013-4_25 · Cited by 1
Cited by
Valproic Acid and Epilepsy: From Molecular Mechanisms to Clinical Evidences
Romoli, M., Mazzocchetti, P., D'Alonzo, R., Siliquini, S., Rinaldi, V. E., Verrotti, A., Calabresi, P., & Costa, C. (2019) · Current Neuropharmacology · doi:10.2174/1570159x17666181227165722 · Cited by 372
Weight changes associated with antiepileptic mood stabilizers in the treatment of bipolar disorder
Grootens, K. P., Meijer, A., Hartong, E. G., Doornbos, B., Bakker, P. R., Al Hadithy, A., Hoogerheide, K. N., Overmeire, F., Marijnissen, R. M., & Ruhe, H. G. (2018) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-018-2517-2 · Cited by 60
DiPaola, F., Molleston, J. P., Gu, J., Cirulli, E. T., Chalasani, N., Barnhart, H., Kleiner, D. E., Hoofnagle, J. H., Fontana, R. J., & US Drug Induced Liver Injury Network (2019) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0000000000002383 · Cited by 36
Metadata
- Authors
- Nanau, R. M., & Neuman, M. G.
- Venue
- Clinical Biochemistry
- Publisher
- Elsevier BV
- Published
- 2013-10
- Volume
- 46
- Issue
- 15
- Pages
- 1323-1338
- ISSN
- 0009-9120 (ISSN-L)
- OpenAlex
- W2031420349
- Cited by
- 321
- References
- 201
- FWCI
- 19.57
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.